Minimal Involvement of P-gp and BCRP in Oral Absorption of Ensitrelvir, An Oral SARS-CoV-2 3C-like Protease Inhibitor, in a Non-Clinical Investigation.
Saved in:
| Title: | Minimal Involvement of P-gp and BCRP in Oral Absorption of Ensitrelvir, An Oral SARS-CoV-2 3C-like Protease Inhibitor, in a Non-Clinical Investigation. |
|---|---|
| Authors: | Watari R; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd.. Electronic address: ryosuke.watari@shionogi.co.jp., Tamura N; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., Yoshida S; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., Kido Y; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd., Matsuzaki T; Laboratory for Drug Discovery and Development, Shionogi & Co., Ltd. |
| Source: | Journal of pharmaceutical sciences [J Pharm Sci] 2024 Sep; Vol. 113 (9), pp. 2871-2878. Date of Electronic Publication: 2024 Jun 15. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Country of Publication: United States NLM ID: 2985195R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1520-6017 (Electronic) Linking ISSN: 00223549 NLM ISO Abbreviation: J Pharm Sci Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1520-6017 |
|---|---|
| DOI: | 10.1016/j.xphs.2024.06.009 |
